For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Clenil Modulite (beclometasone) - Asthma
PAD Profile : Clenil Modulite (beclometasone) - Asthma
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Fostair NEXThaler (beclometasone and formoterol)
- Montelukast
- Theophylline
- Easyhaler (Salbutamol)
- Easyhaler (Beclometasone)
- Easyhaler (Budesonide)
- Fostair (Beclometasone and formoterol)
- Budelin Novolizer (budesonide)
- Dupilumab
- Airflusal (Salmeterol/Fluticasone) MDI
- Aerivio Spiromax (Fluticasone/Salmeterol) DPI
- Ventolin Accuhaler (salbutamol)
- Sereflo Ciphaler (Salmeterol / Fluticasone) DPI
- Campona Airmaster (Salmeterol / Fluticasone) DPI
- Salbutamol
- Terbutaline sulphate
- Budesonide
- Salamol Easi-Breathe
Other Indications
Additional Documents
Committee Recommendations
Clenil Modulite® (beclometasone) MDI plus spacer (Volumatic, Able Spacer, Optichamber) or Qvar (beclometasone) MDI plus spacer (Aerochamber plus, Able Spacer, Optichamber) are the locally preferred ICS devices.
If an alternative device is necessary, consider:
Easyhaler® Beclometasone (DPI) - not licensed in under 18 years
Qvar Easi-Breathe® (breath activated) - not licensed in under 12 years
Easyhaler® Budesonide may be considered as an additional alternative in patients aged 12-17 if these other preferred, licensed devices are not suitable
Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion.
See Asthma Guidelines below.